Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous T Cells Modified by Chimeric Antigen Receptor Targeting EpCAM for Clinical Research on Advanced Digestive System Malignancies

NCT05028933 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT05028933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous T Cells Modified by Chimeric Antigen Receptor Targeting EpCAM for Clinical Research on Advanced Digestive System Malignancies
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2021
Completion date
December 31, 2024
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced colorectal cancer, advanced gastric cancer, advanced hepatocellular carcinoma, advanced pancreatic cancer